Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6492-6502

  Mohan, Chandra ^a   Yu, Ying ^b   Morel, Laurence ^b   Yang, Ping ^b   Wakeland, Edward K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; CHROMOSOME 7; CONTROLLED STUDY; EPISTASIS; IMMUNOGENETICS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, T-INDEPENDENT; APOPTOSIS; CHROMOSOME MAPPING; DINITROBENZENES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPTENS; HEMOCYANIN; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; MALE; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, INBRED NZB; T-LYMPHOCYTES;

EID: 0033151971     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Mohan, C., and S. K. Datta. 1995. Lupus: key pathogenic mechanisms and contributing factors, Clin. Immunol. Immunopathol. 77:209.
2. Theofilopoulos, A. N. 1995. The basis of autoimmunity. I. Mechanisms of aberrant self-recognition. Immunol. Today 16:90.
3. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85:303.
4. Wakeland, E. K., L. Morel, C. Mohan, and M. Yui. 1997. Genetic dissection of lupus nephritis in murine models of SLE. J. Clin. Immunol. 17:272.
5. Vyse, T. J., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85:311.
6. Kono, D. H., and A. N. Theofilopoulos. 1996. Genetic contributions to SLE. J. Autoimmun. 9:437.
7. Rudofsky, U. H., B. D. Evans, S. L. Balaban, V. D. Mottironi, and A. E. Gabrielsen. 1993. Differences in expression of lupus nephritis in New Zealand Mixed H-2z homozygous inbred strains of mice derived from New Zealand Black and New Zealand White mice: origins and initial characterization. Lab. Invest. 68:419.
8. Mohan, C., L. Morel, P. Yang, and E. K. Wakeland. 1998. Splenic B1a cell expansion in NZM2410 lupus strain, with strong antigen presenting capability. Arthritis Rheum. 41:1652.
9. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219.
10. Kono, D. H., R. W. Burlingame, D. G. Owens, A. Kuramochi, R. S. Balderas, D. Balomenos, and A. N. Theofilopoulos. 1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91:10168.
11. lpr mice. J. Clin. Invest. 101:696.
12. lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645.
13. Wakeland, E. K., L. Morel, K. Achey, M. E. Yui, and J. A. Longmate. 1998. Speed congenic: a classic technique moves into the fast lane (relatively speaking). Immunol. Today 18:473.
14. Morel, L., Y. Yu, K. R. Blenman, R. A. Caldwell, and E. K. Wakeland. 1996. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm. Genome 7:335.
15. Morel, L., C. Mohan, Y. Yu, B. Croker, X.-H. Tian, A. Deng, and E. K. Wakeland. 1997. Functional dissection of SLE pathogenesis using congenic mouse strains. J. Immunol. 158:6019.
16. Mohan, C., L. Morel, B. Croker, P. Yang, and E. K. Wakeland. 1997. Genetic dissection of SLE pathogenesis: Sle2 on murine chromosome 4 leads to B-cell hyperactivity. J. Immunol. 159:454.
17. Mohan, C., E. Alas, L. Morel, P. Yang, and E. K. Wakeland. 1997. Genetic dissection of SLE pathogenesis: Sle1 on murine chromosome 1 leads to loss of tolerance to H2A/H2B/DNA subnucleosomes. J. Clin. Invest. 101:1362.
18. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367.
19. Mohan, C., Y. Shi, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470.
20. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and Bow cytometry. J. Immunol. Methods 139:271.
21. Vermes, I., C. Haanen, N. H. Steffens, and C. Reutelingsperger. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184:39.
22. Rozzo, S. J., C. G. Drake, B. L. Chiang, M. E. Gershwin, and B. L. Kotzin. 1994. Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. J. Immunol. 153:1340.
23. 1 mice: evidence for abnormality of the mesenteric lymph node cells. J. Immunol. 132:1265.
24. Giese, T., and W. F. Davidson. 1992. Evidence for early-onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J. Immunol. 149:3097.
25. Horwitz, D. A., and W. T. Stohl. 1993. T lymphocytes, cytokines, and immune regulation in systemic lupus erythematosus. In Dubois' Lupus Erythematosus. D. J. Wallace, and B. H. Hahn, eds. Lea and Febiger, Philadelphia, pp. 83-96.
26. Chen, S. Y., Y. Takeoka, A. A. Ansari, R. Boyd, D. M. Klinman, and M. E. Gershwin. 1996. The natural history of disease expression in CD4 and CD8 gene-deleted New Zealand Black (NZB) mice. J. Immunol. 157:2676.
27. Chesnutt, M. S., B. K. Finck, N. Killeen, M. K. Connolly, H. Goodman, and D. Wofsy. 1998. Enhanced lymphoproliferation and diminished autoimmunity in CD4-dencient MRL/lpr mice. Clin. Immunol. Immunopathol. 87:23.
28. 1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378.
29. Datta, S. K., H. Patel, and D. Berry. 1987. Induction of a cationic shift in IgG anti-DNA autoantibodies: role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J. Exp. Med. 165:1252.
30. 1 murine SLE model. J. Immunol. 138:3185.
31. Sobel, E. S., V. N. Kakkanaiah, M. Kakkanaiah, R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1994. T-B collaboration for autoantibody production in Ipr mice is cognate and MHC-restricted. J. Immunol. 152:6011.
32. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143:103.
33. Vassilopoulos, D., B. Kovacs, and G. C. Tsokos. 1995. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol. 155:2269.
34. Liossis, S. N., X. Z. Ding, G. J. Dennis, and G. C. Tsokos. 1998. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythemalosus: deficient expression of the T cell receptor ζ chain. J. Clin. Invest. 101:1448.
35. Tsokos, G. C. 1992. Lymphocyte abnormalities in human lupus. Clin. Immunol. Immunopathol. 63:7.
36. Dayal, A. K., and G. M. Kammer. 1996. The T cell enigma in lupus. Arthritis Rheum. 39:23.
37. Kammer, G. M., I. U. Khan, J. A. Kammer, I. Olorenshaw, and D. Mathis. 1996. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. II. Abnormal isozyme kinetics. J. Immunol. 157:2690.
38. + T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J. Immunol. 151:7233.
39. Izui, S., V. E. Kelley, K. Masuda, H. Yoshida, J. B. Roths, and E. D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
40. Kovacs, B., D. Vassilopoulos, S. A. Vogelgesang, and G. C. Tsokos. 1996. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 81:293.
41. Budagyan, V. M., E. G. Bulanova, N. I. Sharova, M. F. Nikonova, M. L. Stanislav, and A. A. Yarylin. 1998. The resistance of activated T-cells from SLE patients to apoptosis induced by human thymic stromal cells. Immunol. Lett. 60:1.
42. + cells of older lupus mice. Eur. J. Immunol. 27:1901.
43. Elkon, K. B. 1994. Apoptosis in SLE: too little or too much? Clin. Exp. Rheumatol 12:553.
44. Kolowos, W., M. Hermann, B. B. Ponner, R. Voll, P. Kern, C. Frank, and J. R. Kalden. 1997. Detection of restricted junctional diversity of peripheral T cells in SLE patients by spectratyping. Lupus 6:701.
45. Mato, T., K. Masuko, Y. Misaki, N. Hirose, K. Ito, Y. Takemoto, K. Izawa, S. Yamamori, T. Kato, K. Nishioka, and K. Yamamoto. 1997. Correlation of clonal T cell expansion with disease activity in systemic lupus erythematosus. Int. Immunol. 9:547.
46. Holbrook, M. R., P. J. Tighe, and R. J. Powell. 1996. Restrictions of T cell receptor β chain repertoire in the peripheral blood of patients with systemic lupus erythematosus. Ann. Rheum. Dis. 55:627.
47. Kaliyaperumal, A., C. Mohan, W. Wu, and S. K. Datta. 1996. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183:2459.
48. Desai-Mehta, A., C. Mao, S. Rajagopalan, T. Robinson, and S. K. Datta. 1995. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J. Clin. Invest. 95:531.
49. Filaci, G., I. Grasso, P. Contini, M. A. Imro, L. Lanza, M. Scudeletti, E. Rossi, F. Puppo, E. Damasio, and F. Indiveri. 1996. dsDNA-, nucleohistone-and DNasc I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: correlation with clinical disease activity. Clin. Exp. Rheumatol. 14:543.
50. Singh, R. R., V. Kumar, F. M. Ebling, S. Southwood, A. Sette, E. E. Sercarz, and B. H. Hahn. 1995. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181: 2017.
51. Duncan, S. R., R. L. Rubin, R. W. Burlingame, S. B. Sinclair, K. W. Pekny, and A. N. Theofilopoulos. 1996. Intrathymic injection of polynucleosomes delays autoantibody production in BXSB mice. Clin. Immunol. Immunopathol. 79:171.
52. Voll, R. E., E.A. Roth, I. Girkontaite, H. Fehr, M. Hermann, H. M. Lorenz, and J. R. Kalden. 1997. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 40:2162.
53. Crow, M. K., A. G. DelGiudice, J. B. Zehetbauer, J. L. Lawson, N. Brot, H. Weissbach, and K. B. Elkon. 1994. Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. J. Clin. Invest. 94:345.
54. Van, P. L., and A. K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280:243.
55. Cohen, P. L., and R. A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
56. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
57. Leonard, W. J., E. W. Shores, and P. E. Love. 1995. Role of the common cytokine receptor Y chain in cytokine signaling and lymphoid development. Immunol. Rev. 148:97.
58. + T cells. Eur. J. Immunol. 25:3053.
59. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P.S. Ohashi, H. Griesser. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268:1472.
60. DiSanto, J. P., W. Muller, G. D. Guy, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor y chain. Proc. Natl. Acad. Sci. USA 92:377.
61. Cao, X., E. W. Shores, L. J. Hu, M. R. Anver, B. L. Kelsall, S. M. Russell, J. Drago, M. Noguchi, A. Grinberg, E. T. Bloom, et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2:223.
62. Nosaka, T., D. J. van, R. A. Tripp, W. E. Thierfelder, B. A. Witthuhn, A. P. McMickle, P. C. Doherty, G. C. Grosveld, and J. N. Ihle. 1995. Defective lymphoid development in mice lacking Jak3. Science 270:800.
63. Park, S. Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, N. Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T. Saito. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3:771.
64. Nakajima, H., E. W. Shores, M. Noguchi, and W. J. Leonard. 1997. The common cytokine receptor y chain plays an essential role in regulating lymphoid homeostasis. J. Exp. Med. 185:189.
65. Nakajima, H., and W. J. Leonard. 1997. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor γ-chain. J. Immunol. 159: 4737.
66. Saijo, K., S. Y. Park, Y. Ishida, H. Arase, and T. Saito. 1997. Crucial role of Jak3 in negative selection of self-reactive T cells. J. Exp. Med. 185:351.
67. DiSanto, J. P., G. D. Guy, A. Fisher, and A. Tarakhovsky. 1996. Critical role for the common cytokine receptor γ chain in intrathymic and peripheral T cell selection. J. Exp. Med. 183:1111.
68. Parijs, L. V., A. Biuckians, A. Ibragimov, F. W. Alt, D. M. Willerford, and A. K. Abbas. 1997. Functional responses and apoptosis of CD25 (IL-2Ra)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158:3738.
69. Kneitz, B., T. Herrmann, S. Yonehara, and A. Schimpl. 1995. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. 25:2572.
70. Perez, V. L., L. V. Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA4 engagement. Immunity 6:411.
71. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
72. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985.
73. Esslinger, C. W., A. Wilson, B. Sordat, F. Beermann, and C. V. Jongeneel. 1997. Abnormal T lymphocyte development induced by targeted overexpression of IkB α. J. Immunol. 158:5075.
74. Boothby, M. R., A. L. Mora, D. C. Scherer, J. A. Brockman, and D. W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive represser of nuclear factor (NF)-kB. J. Exp. Med. 185:1897.
75. Weih, F., G. Warr, H. Yang, and R. Bravo. 1997. Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 158:5211.
76. Chan, A. C., T. A. Kadlecek, M. E. Elder, A. H. Filipovich, W. L. Kuo, M. Iwashima, T. G. Parslow, and A. Weiss. 1994. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264: 1599.
77. Elder, M. E., D. Lin, J. Clever, A. C. Chan, T. J. Hope, A. Weiss, and T. G. Parslow. 1994. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264:1596.
78. Hang, L. M., M. T. Aguado, F. J. Dixon, and A. N. Theofilopoulos. 1985. Induction of severe autoimmune disease in normal mice by simultaneous action of multiple immunostimulators. J. Exp. Med. 161:423.
79. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenetic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445.
80. O'Keefe, T. L., G. T. Williams, S. L. Davies, and M. S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274:798.
81. Sato, S., A. S. Miller, M. Inaoki, C. B. Bock, P. J. Jansen, M. L. Tang, and T. F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-dencient mice. Immunity 5:551.
82. Nitschke, L., R. Carsetti, B. Ocker, G. Kohler, and M. C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7:133.
83. Otipoby, K. L., K. B. Andersson, K. E. Draves, S. J. Klaus, A. G. Farr, J. D. Kerner, R. M. Perlmutter, C. L. Law, and E. A. Clark. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384:634.
84. Christ, M., F. N. McCartney, A. B. Kulkarni, J. M. Ward, D. E. Mizel, C. L. Mackall, R. E. Gress, K. L. Hines, H. Tian, S. Karlsson. 1994. Immune dysregulalion in TGF-β1-deficient mice. J. Immunol. 153:1936.
85. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90:770.
86. Dang, H., A. G. Geiser, J. J. Letterio, T. Nakabayashi, L. Kong, G. Fernandes, and N. Talal. 1995. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-β knockout mice. J. Immunol. 155:3205.
87. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693.
88. Ong, S. T., M. L. Hackbarth, L. C. Degenstein, D. A. Baunoch, J. Anastasi, and T. W. McKeithan. 1998. Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 Iransgenic mice. Oncogene 16:2333.
89. Nadler, M. J., P. A. McLean, B. G. Neel, and H. H. Wortis. 1997. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines. J. Immunol. 159:4233.
90. Mokan, C., L. Morel, P. Yang, H. Watanabe, B. Croker, G. Gilkeson, and E. K. Wakeland. 1999. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. In press.